Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure.
Pathol Res Pract
; 250: 154816, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37725880
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Pathol Res Pract
Year:
2023
Type:
Article
Affiliation country:
Saudi Arabia